114 related articles for article (PubMed ID: 2723107)
1. Obesity and beta-blockers: influence of body fat on their kinetics and cardiovascular effects.
Galletti F; Fasano ML; Ferrara LA; Groppi A; Montagna M; Mancini M
J Clin Pharmacol; 1989 Mar; 29(3):212-6. PubMed ID: 2723107
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.
Jordan J; Engeli S; Boschmann M; Weidinger G; Luft FC; Sharma AM; Kreuzberg U
J Hypertens; 2005 Dec; 23(12):2313-8. PubMed ID: 16269974
[TBL] [Abstract][Full Text] [Related]
3. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
[TBL] [Abstract][Full Text] [Related]
4. Treatment with beta-blockers--the value of an even plasma concentration over 24 h.
Agewall S; Kendall M
J Clin Pharm Ther; 1997 Jun; 22(3):171-9. PubMed ID: 9447471
[TBL] [Abstract][Full Text] [Related]
5. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
6. β-blockers: a review of their pharmacological and physiological diversity in hypertension.
Ripley TL; Saseen JJ
Ann Pharmacother; 2014 Jun; 48(6):723-33. PubMed ID: 24687542
[TBL] [Abstract][Full Text] [Related]
7. Effect of beta-blockade on baroreflex sensitivity and cardiovascular autonomic function tests in patients with coronary artery disease.
Airaksinen KE; Niemelä MJ; Huikuri HV
Eur Heart J; 1994 Nov; 15(11):1482-5. PubMed ID: 7835362
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
9. [Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs].
Lazebnik LB; Mikheeva OM; Drozdov VN; Petrakov AV; Sil'vestrova SIu
Eksp Klin Gastroenterol; 2008; (2):22-6. PubMed ID: 19148988
[No Abstract] [Full Text] [Related]
10. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
[TBL] [Abstract][Full Text] [Related]
11. Lipid-soluble and water-soluble beta-blockers. Comparison of the central nervous system depressant effect.
Gengo FM; Huntoon L; McHugh WB
Arch Intern Med; 1987 Jan; 147(1):39-43. PubMed ID: 3541824
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of atenolol and metoprolol in the treatment of hypertension.
Rasmussen S; Arnung K; Eskildsen PC; Nielsen PE
Br J Clin Pharmacol; 1981 Dec; 12(6):887-91. PubMed ID: 7340890
[TBL] [Abstract][Full Text] [Related]
13. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
[TBL] [Abstract][Full Text] [Related]
14. Obesity as a determinant for response to antihypertensive treatment.
Schmieder RE; Gatzka C; Schächinger H; Schobel H; Rüddel H
BMJ; 1993 Aug; 307(6903):537-40. PubMed ID: 8400973
[TBL] [Abstract][Full Text] [Related]
15. The effect of beta-blockers on mental performance on older hypertensive patients.
Gengo FM; Fagan SC; de Padova A; Miller JK; Kinkel PR
Arch Intern Med; 1988 Apr; 148(4):779-84. PubMed ID: 3281618
[TBL] [Abstract][Full Text] [Related]
16. [Protection of the hypertensive patient: comparative atenolol-metoprolol study].
Mazzari M; Coppola E; Montenero AS; Schiavoni G; Domenichelli B; Mongiardo R; Pennestrì F
Cardiologia; 1982; 27(8):753-63. PubMed ID: 6892449
[No Abstract] [Full Text] [Related]
17. No difference in general well-being during antihypertensive treatment with atenolol or metoprolol CR.
Dahlöf C; Almkvist G; Dimenäs E; Jern S; Johansson B; Larsson C; Lorentzon S; Nilsson D; Nygaard-Pedersen L
Ann Clin Res; 1988; 20 Suppl 48():42-50. PubMed ID: 3250317
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
Klein G; Berger J; Olsson G; Menzel T
J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study.
Ekbom T; Dahlöf B; Hansson L; Lindholm LH; Scherstén B; Wester PO
J Hypertens; 1992 Dec; 10(12):1525-30. PubMed ID: 1338084
[TBL] [Abstract][Full Text] [Related]
20. [Protection of the hypertensive patient: comparative study of atenolol and metoprolol].
Mazzari M; Coppola E; Montenero AS; Schiavoni G; Domenichelli B; Mongiardo R; Pennestrì F
Cardiologia; 1982; 27(8):753-63. PubMed ID: 6765444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
